Compare S&P500 ETF (SPY) vs Zoetis Inc (ZTS) Price & Performance

S&P500 ETFTrade

Zoetis IncTrade

Price performance (Past 24H)

Key statistics

S&P500 ETF vs Zoetis Inc — how do they compare? S&P500 ETF trades at $747.79, while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Zoetis Inc pays a 2.78% dividend while S&P500 ETF pays none, and S&P500 ETF is trading nearer its 52-week high, Zoetis Inc nearer its low. Which is the better fit depends on your goals.

	SPY	ZTS
52-Week High	$759.55	$156.76
52-Week Low	$621.75	$71.91
Market Cap	—	$31.95B
Sector	—	Health
Enterprise Value	—	$39.24B
Dividend Yield	—	2.78%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SPY

Vanguard's VEA ETF offers low-cost developed market exposure beyond the U.S., balancing diversification and risk.24/7 Wall Street · 8 hours agoNeutral John Hancock Financial Opportunities Fund offers 6.5% growing dividend, beating S&P 500 and financial ETFs.Forbes · 15 hours agoBullish XLK ETF hides high concentration risk in top tech stocks despite low fees.24/7 Wall Street · 1 day agoNeutral View details →

ZTS

Class action lawsuits filed against CALX, AVAV, ZTS, and LCID over alleged misleading statements.GlobeNewsWire · 4 days agoBearish View details →

About S&P500 ETF

The ETF is designed to track the performance of the securities and the stocks in the S&P 500 Index. To maintain the composition and weightings, the advisor adjusts the ETF from time to time to conform to periodic changes in the index target.

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.